These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

352 related items for PubMed ID: 17483326

  • 1. Hypoxia and hypoxia-inducible factor-1 expression enhance osteolytic bone metastases of breast cancer.
    Hiraga T, Kizaka-Kondoh S, Hirota K, Hiraoka M, Yoneda T.
    Cancer Res; 2007 May 01; 67(9):4157-63. PubMed ID: 17483326
    [Abstract] [Full Text] [Related]

  • 2. Hypoxia-inducible factor is expressed in giant cell tumour of bone and mediates paracrine effects of hypoxia on monocyte-osteoclast differentiation via induction of VEGF.
    Knowles HJ, Athanasou NA.
    J Pathol; 2008 May 01; 215(1):56-66. PubMed ID: 18283716
    [Abstract] [Full Text] [Related]

  • 3. Stimulation of cyclooxygenase-2 expression by bone-derived transforming growth factor-beta enhances bone metastases in breast cancer.
    Hiraga T, Myoui A, Choi ME, Yoshikawa H, Yoneda T.
    Cancer Res; 2006 Feb 15; 66(4):2067-73. PubMed ID: 16489006
    [Abstract] [Full Text] [Related]

  • 4. Significance of HIF-1-active cells in angiogenesis and radioresistance.
    Harada H, Kizaka-Kondoh S, Li G, Itasaka S, Shibuya K, Inoue M, Hiraoka M.
    Oncogene; 2007 Nov 29; 26(54):7508-16. PubMed ID: 17563752
    [Abstract] [Full Text] [Related]

  • 5. Bone morphogenetic protein 7 in the development and treatment of bone metastases from breast cancer.
    Buijs JT, Henriquez NV, van Overveld PG, van der Horst G, Que I, Schwaninger R, Rentsch C, Ten Dijke P, Cleton-Jansen AM, Driouch K, Lidereau R, Bachelier R, Vukicevic S, Clézardin P, Papapoulos SE, Cecchini MG, Löwik CW, van der Pluijm G.
    Cancer Res; 2007 Sep 15; 67(18):8742-51. PubMed ID: 17875715
    [Abstract] [Full Text] [Related]

  • 6. E-cadherin expression in human breast cancer cells suppresses the development of osteolytic bone metastases in an experimental metastasis model.
    Mbalaviele G, Dunstan CR, Sasaki A, Williams PJ, Mundy GR, Yoneda T.
    Cancer Res; 1996 Sep 01; 56(17):4063-70. PubMed ID: 8752180
    [Abstract] [Full Text] [Related]

  • 7. Selective killing of hypoxia-inducible factor-1-active cells improves survival in a mouse model of invasive and metastatic pancreatic cancer.
    Kizaka-Kondoh S, Itasaka S, Zeng L, Tanaka S, Zhao T, Takahashi Y, Shibuya K, Hirota K, Semenza GL, Hiraoka M.
    Clin Cancer Res; 2009 May 15; 15(10):3433-41. PubMed ID: 19417024
    [Abstract] [Full Text] [Related]

  • 8. Tumor-derived interleukin-8 stimulates osteolysis independent of the receptor activator of nuclear factor-kappaB ligand pathway.
    Bendre MS, Margulies AG, Walser B, Akel NS, Bhattacharrya S, Skinner RA, Swain F, Ramani V, Mohammad KS, Wessner LL, Martinez A, Guise TA, Chirgwin JM, Gaddy D, Suva LJ.
    Cancer Res; 2005 Dec 01; 65(23):11001-9. PubMed ID: 16322249
    [Abstract] [Full Text] [Related]

  • 9. Antitumor effect of TAT-oxygen-dependent degradation-caspase-3 fusion protein specifically stabilized and activated in hypoxic tumor cells.
    Harada H, Hiraoka M, Kizaka-Kondoh S.
    Cancer Res; 2002 Apr 01; 62(7):2013-8. PubMed ID: 11929818
    [Abstract] [Full Text] [Related]

  • 10. The heat shock protein 90 inhibitor, 17-allylamino-17-demethoxygeldanamycin, enhances osteoclast formation and potentiates bone metastasis of a human breast cancer cell line.
    Price JT, Quinn JM, Sims NA, Vieusseux J, Waldeck K, Docherty SE, Myers D, Nakamura A, Waltham MC, Gillespie MT, Thompson EW.
    Cancer Res; 2005 Jun 01; 65(11):4929-38. PubMed ID: 15930315
    [Abstract] [Full Text] [Related]

  • 11. CITED4 inhibits hypoxia-activated transcription in cancer cells, and its cytoplasmic location in breast cancer is associated with elevated expression of tumor cell hypoxia-inducible factor 1alpha.
    Fox SB, Bragança J, Turley H, Campo L, Han C, Gatter KC, Bhattacharya S, Harris AL.
    Cancer Res; 2004 Sep 01; 64(17):6075-81. PubMed ID: 15342390
    [Abstract] [Full Text] [Related]

  • 12. A bone-seeking clone exhibits different biological properties from the MDA-MB-231 parental human breast cancer cells and a brain-seeking clone in vivo and in vitro.
    Yoneda T, Williams PJ, Hiraga T, Niewolna M, Nishimura R.
    J Bone Miner Res; 2001 Aug 01; 16(8):1486-95. PubMed ID: 11499871
    [Abstract] [Full Text] [Related]

  • 13. Insulin-dependent leptin expression in breast cancer cells.
    Bartella V, Cascio S, Fiorio E, Auriemma A, Russo A, Surmacz E.
    Cancer Res; 2008 Jun 15; 68(12):4919-27. PubMed ID: 18559540
    [Abstract] [Full Text] [Related]

  • 14. Nuclear factor-kappaB-dependent mechanisms in breast cancer cells regulate tumor burden and osteolysis in bone.
    Gordon AH, O'Keefe RJ, Schwarz EM, Rosier RN, Puzas JE.
    Cancer Res; 2005 Apr 15; 65(8):3209-17. PubMed ID: 15833852
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Nuclear co-localization and functional interaction of COX-2 and HIF-1α characterize bone metastasis of human breast carcinoma.
    Maroni P, Matteucci E, Luzzati A, Perrucchini G, Bendinelli P, Desiderio MA.
    Breast Cancer Res Treat; 2011 Sep 15; 129(2):433-50. PubMed ID: 21069452
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Identification of thioredoxin-interacting protein 1 as a hypoxia-inducible factor 1alpha-induced gene in pancreatic cancer.
    Baker AF, Koh MY, Williams RR, James B, Wang H, Tate WR, Gallegos A, Von Hoff DD, Han H, Powis G.
    Pancreas; 2008 Mar 15; 36(2):178-86. PubMed ID: 18376310
    [Abstract] [Full Text] [Related]

  • 20. Hypoxia-inducible factor-1 in human breast and prostate cancer.
    Kimbro KS, Simons JW.
    Endocr Relat Cancer; 2006 Sep 15; 13(3):739-49. PubMed ID: 16954428
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.